Page last updated: 2024-08-17

isosorbide dinitrate and cardiovascular agents

isosorbide dinitrate has been researched along with cardiovascular agents in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19904 (8.70)18.7374
1990's6 (13.04)18.2507
2000's22 (47.83)29.6817
2010's13 (28.26)24.3611
2020's1 (2.17)2.80

Authors

AuthorsStudies
Adachi, H; Kodama, K; Ogawa, T; Ohhara, H1
Draganov, V; Manolov, P; Stankusheva, G1
Bochkareva, EV; Kokurina, EV; Martsevich, SIu; Shakarova, SSh; Vygodin, VA1
Fiedler, VB; Nitz, RE1
Sanchez-Cascos, A1
Follath, F1
Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C1
Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B1
Gen, H; Himura, Y; Iga, K; Inoko, M; Izumi, C; Kitaguchi, S; Kondou, H; Konishi, T; Tamura, T1
Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY1
Hayashi, T; Ishikawa, K; Kanamasa, K; Kimura, A; Kitayama, K; Miyataka, M; Takenaka, T; Yabushita, H; Yamamoto, T1
Craven, R1
Akdeniz, B; Aslan, O; Badak, O; Goldeli, O; Guneri, S; Keskin, V; Kirimli, O; Tekin, U1
Cohn, JN; Franciosa, JA; Taylor, AL; Worcel, M1
Kugiyama, K; Yasue, H1
Kahn, J3
Kopff, A; Kopff, M; Kowalczyk, E1
Duster, T1
Saul, S1
Deng, TT; Li, XM; Luo, WJ; Wang, X; Wu, HL1
Hoffman, S1
Bibbins-Domingo, K; Fernandez, A2
Stockbridge, NL; Temple, R1
Adams, K; Carson, P; Cohn, JN; Ferdinand, K; Ofili, E; Olukotun, AY; Sabolinski, ML; Tam, SW; Taylor, AL; Taylor, M; Worcel, M; Yancy, CW; Ziesche, S1
Kahn, JD1
Fullerton, SM; Goering, S; Yu, JH1
Leslie, SJ; Megson, IL1
Abrahams, Z; Francis, GS; Mullens, W; Sokos, G; Starling, RC; Tang, WH; Taylor, DO; Young, JB1
Dries, DL; McNamara, D; Rame, JE; Sabolinski, ML; Tam, SW; Worcel, M; Wu, AH1
Chedgy, F; Howlett, DC; Inglis, C1
Clark, M; Pan, L; Payne, J1
Lim, WY; Woldman, S1
Ge, L; Gong, Y; Jiang, L; Liu, J; Liu, Q; Shi, Y; Zheng, C; Zhu, J1
Daida, H; Hiki, M; Nakazato, Y; Tokano, T1
Dixit, D; Kimborowicz, K1
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F1
Marković-Peković, V; Škrbić, R1
Adhyaru, B; Raj, L1
Ağır, AA; Baydemir, C; Bozyel, S; Kandemir, AŞ; Karaüzüm, İY; Karaüzüm, K; Kozdağ, G; Ural, D1
Wu, A1
Brewster, LM1
Chakrapani, M; Kamath, A; Padakanti, A; Shenoy, A1
Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH1

Reviews

9 review(s) available for isosorbide dinitrate and cardiovascular agents

ArticleYear
[Drug therapy in angina pectoris].
    Praxis, 1995, Oct-17, Volume: 84, Issue:42

    Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vasospasm; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Vasodilator Agents

1995
[Antianginal drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52 Suppl, Issue:Pt 1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Nitroglycerin; Vasodilator Agents

1994
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.
    Yale journal of health policy, law, and ethics, 2004,Winter, Volume: 4, Issue:1

    Topics: Black or African American; Cardiovascular Agents; Commerce; Drug Approval; Drug Combinations; Drug Labeling; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Retrospective Studies; United States

2004
LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders.
    Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:3

    Topics: Animals; Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Disease Models, Animal; Drug Tolerance; Fibrinolytic Agents; Humans; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Myocardial Ischemia; Nitric Oxide Donors; Patents as Topic; Structure-Activity Relationship; Treatment Outcome

2009
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists

2013
Pharmacologic management of chronic stable angina.
    JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents

2015
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Swiss medical weekly, 2016, Volume: 146

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents

2016
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Postgraduate medical journal, 2016, Volume: 92, Issue:1094

    Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents

2016
Heart Failure.
    Annals of internal medicine, 2018, 06-05, Volume: 168, Issue:11

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors

2018

Trials

5 trial(s) available for isosorbide dinitrate and cardiovascular agents

ArticleYear
Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion.
    The Canadian journal of cardiology, 2002, Volume: 18, Issue:8

    Topics: Administration, Sublingual; Adult; Cardiovascular Agents; Female; Humans; Infusions, Intravenous; Isoproterenol; Isosorbide Dinitrate; Male; Middle Aged; Sensitivity and Specificity; Syncope; Syncope, Vasovagal; Tilt-Table Test

2002
The African-American Heart Failure Trial: background, rationale and significance.
    Journal of the National Medical Association, 2002, Volume: 94, Issue:9

    Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Research Design

2002
[Trial study on DENG Tie-tao's coronary heart disease capsules in improving patients' quality of life].
    Chinese journal of integrative medicine, 2005, Volume: 11, Issue:3

    Topics: Aged; Angina Pectoris; Capsules; Cardiovascular Agents; Coronary Disease; Drugs, Chinese Herbal; Female; Humans; Isosorbide Dinitrate; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Plant Preparations; Quality of Life; Salvia miltiorrhiza; Single-Blind Method; Treatment Outcome

2005
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
    Circulation, 2007, Apr-03, Volume: 115, Issue:13

    Topics: Adult; Aged; Arthralgia; Biomarkers; Black or African American; Cardiovascular Agents; Cause of Death; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Combinations; Heart Failure; Heart Transplantation; Hospitalization; Humans; Hydralazine; Hypotension; Isosorbide Dinitrate; Kaplan-Meier Estimate; Middle Aged; Mortality; Natriuretic Peptide, Brain; Nitric Oxide Donors; Proportional Hazards Models; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents

2007
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
    Journal of the American Heart Association, 2021, 02-02, Volume: 10, Issue:3

    Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents

2021

Other Studies

32 other study(ies) available for isosorbide dinitrate and cardiovascular agents

ArticleYear
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs.
    Japanese journal of pharmacology, 1992, Volume: 60, Issue:2

    Topics: Anesthesia; Animals; Benzopyrans; Cardiovascular Agents; Catechols; Clonidine; Coronary Vessels; Cromakalim; Electrocardiography; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isosorbide Dinitrate; Male; Nifedipine; Pyrroles; Vasodilator Agents; Vasopressins

1992
[Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
    Vutreshni bolesti, 1987, Volume: 26, Issue:2

    Topics: Acebutolol; Adult; Aged; Cardiovascular Agents; Coronary Disease; Delayed-Action Preparations; Drug Evaluation; Female; Flavonoids; Hemodynamics; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Phenethylamines; Tablets; Time Factors

1987
[Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
    Kardiologiia, 1985, Volume: 25, Issue:4

    Topics: Angina Pectoris; Cardiovascular Agents; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Physical Endurance; Propranolol

1985
Effects of molsidomine, nitroglycerin, and isosorbide dinitrate on the coronary circulation, myocardial oxygen consumption, and haemodynamics in anaesthetized dogs.
    Naunyn-Schmiedeberg's archives of pharmacology, 1981, Volume: 317, Issue:1

    Topics: Animals; Cardiovascular Agents; Coronary Circulation; Dogs; Female; Heart; Hemodynamics; Isosorbide Dinitrate; Male; Molsidomine; Morpholines; Myocardium; Nitroglycerin; Oxadiazoles; Oxygen Consumption; Sydnones

1981
Evaluation of effect of drugs on the exercise ECG.
    Cardiology, 1981, Volume: 68 Suppl 2

    Topics: Atenolol; Blood Pressure; Cardiovascular Agents; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Propranolol; Verapamil

1981
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
    Cardiology, 1993, Volume: 83, Issue:1-2

    Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity

1993
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:3

    Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists

1996
Two cases of hypertrophic cardiomyopathy with coronary vasospasm.
    Japanese circulation journal, 1998, Volume: 62, Issue:11

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris, Variant; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Electrocardiography; Humans; Isosorbide Dinitrate; Male; Middle Aged

1998
Successful management of intractable coronary spasm with a coronary stent.
    Japanese circulation journal, 2000, Volume: 64, Issue:11

    Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation

2000
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coronary Vasospasm; Delayed-Action Preparations; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Recurrence; Retrospective Studies; Treatment Outcome

2000
Tailored treatments.
    Trends in pharmacological sciences, 2001, Volume: 22, Issue:5

    Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate

2001
[Inhibition of adenosine deaminase activity by drugs influencing the cardiovascular system].
    Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 111, Issue:6

    Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Aspirin; Cardiovascular Agents; Cardiovascular System; Deoxyadenosines; Female; Fibrinolytic Agents; Isoenzymes; Isosorbide Dinitrate; Male; Metoprolol; Molsidomine; Rabbits; Random Allocation; Simvastatin; Vasodilator Agents; Vasomotor System

2004
Medicine. Race and reification in science.
    Science (New York, N.Y.), 2005, Feb-18, Volume: 307, Issue:5712

    Topics: Bias; Cardiovascular Agents; Crime; Databases, Nucleic Acid; Drug Combinations; Forensic Sciences; Gene Frequency; Genetic Variation; Genetics, Medical; Heart Diseases; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Racial Groups

2005
U.S. to review drug intended for one race.
    The New York times on the Web, 2005, Jun-13

    Topics: Black or African American; Cardiovascular Agents; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing of Health Services; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration

2005
Misreading race and genomics after BiDil.
    Nature genetics, 2005, Volume: 37, Issue:7

    Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Genomics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration

2005
"Racially-tailored" medicine unraveled.
    The American University law review, 2005, Volume: 55, Issue:2

    Topics: Cardiovascular Agents; Civil Rights; Delivery of Health Care; Drug Combinations; Ethics Committees, Research; Federal Government; Financing, Government; Genetic Research; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; National Institutes of Health (U.S.); Organizational Policy; Patient Rights; Pharmacogenetics; Prejudice; Racial Groups; State Government; United States

2005
BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
    Annals of internal medicine, 2007, Jan-02, Volume: 146, Issue:1

    Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration

2007
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
    Annals of internal medicine, 2007, Jan-02, Volume: 146, Issue:1

    Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration

2007
BiDil for heart failure in black patients.
    Annals of internal medicine, 2007, Aug-07, Volume: 147, Issue:3

    Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration

2007
BiDil for heart failure in black patients.
    Annals of internal medicine, 2007, Aug-07, Volume: 147, Issue:3

    Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration

2007
Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
    Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees, 2009,Winter, Volume: 18, Issue:1

    Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Drug Design; Ethical Theory; Healthcare Disparities; Heart Failure; History, 20th Century; History, 21st Century; Humans; Hydralazine; Isosorbide Dinitrate; Social Justice; United States

2009
Exploiting race in drug development: BiDil's interim model of pharmacogenomics.
    Social studies of science, 2008, Volume: 38, Issue:5

    Topics: Cardiovascular Agents; Drug Combinations; History, 20th Century; History, 21st Century; Humans; Hydralazine; Intellectual Property; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration

2008
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
    The American journal of cardiology, 2009, Apr-15, Volume: 103, Issue:8

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged

2009
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
    Circulation. Heart failure, 2009, Volume: 2, Issue:6

    Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genetic Predisposition to Disease; Heart Failure, Systolic; Hospitalization; Humans; Hydralazine; Immunoassay; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Mutation; Natriuretic Peptide, Brain; Phenotype; Proportional Hazards Models; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Serine Endopeptidases; Treatment Outcome; United States

2009
A case of recurrent ventricular tachycardia.
    BMJ (Clinical research ed.), 2011, Jun-01, Volume: 342

    Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin

2011
Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
    The Journal of the Oklahoma State Medical Association, 2011, Volume: 104, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Drug Combinations; Evidence-Based Medicine; Heart Failure, Systolic; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Renal Insufficiency; Treatment Outcome

2011
A novel multi-unit tablet for treating circadian rhythm diseases.
    AAPS PharmSciTech, 2013, Volume: 14, Issue:2

    Topics: Administration, Oral; Angina Pectoris; Cardiovascular Agents; Cellulose; Chemistry, Pharmaceutical; Chronobiology Disorders; Delayed-Action Preparations; Drug Carriers; Excipients; Hypromellose Derivatives; Isosorbide Dinitrate; Kinetics; Methacrylates; Methylcellulose; Microscopy, Electron, Scanning; Polymers; Solubility; Tablets; Technology, Pharmaceutical

2013
Recurrent ventricular fibrillation under sufficient medical treatment in patient with coronary artery spasm.
    BMJ case reports, 2013, Jul-02, Volume: 2013

    Topics: Cardiovascular Agents; Coronary Vasospasm; Defibrillators, Implantable; Diagnosis, Differential; Diltiazem; Echocardiography; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Middle Aged; Nicorandil; Recurrence; Treatment Outcome; Ventricular Fibrillation

2013
Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina.
    Vojnosanitetski pregled, 2016, Volume: 73, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Aminophylline; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Bosnia and Herzegovina; Bronchodilator Agents; Calcium Channel Blockers; Cardiovascular Agents; Digoxin; Female; Humans; Hypoglycemic Agents; Isosorbide Dinitrate; Male; Polypharmacy; Retrospective Studies; Sex Factors; Vasodilator Agents

2016
Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis.
    Journal of cardiac failure, 2017, Volume: 23, Issue:4

    Topics: Aged; Cardiovascular Agents; Female; Heart Failure; Hospitalization; Humans; Isosorbide Dinitrate; Male; Middle Aged; Mortality; Propensity Score; Retrospective Studies; Risk Factors; Stroke Volume; Survival Analysis; Turkey; Ventricular Dysfunction, Left

2017
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
    ESC heart failure, 2019, Volume: 6, Issue:3

    Topics: Black People; Cardiovascular Agents; Cross-Sectional Studies; Databases, Pharmaceutical; Drug Combinations; Drug Prescriptions; Europe; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate

2019
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition.
    Acta medica (Hradec Kralove), 2019, Volume: 62, Issue:4

    Topics: Cardiovascular Agents; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged

2019